Lilly - Exploring Global Olumiant Experience in Treating Rheumatoid Arthritis: Different Continents, Different Circumstances


Industry room 4
English
Satellite Symposia
02 June 2021 18:15 - 19:45

Eli Lilly & Company welcomes you to this virtual satellite symposium entitled “Exploring Global Olumiant Experience in Treating Rheumatoid Arthritis: Different Continents, Different Circumstances”. These presentations are in line with the EMA-approved label of Olumiant. For the latest approved Olumiant label please check the Lilly company profile on this platform and the EMA website.

Learning Objectives:

  • As the number of treatment options increase and guidelines progressively evolve, we’ll discuss what this means in clinical practice and when, and if, it is appropriate to modify existing therapeutic management strategies.
  • Medicine works by individual patient identification; and with varying heterogeneity in RA patients depending on geography, this symposium will explore the latest baricitinib data from clinical trials, real-world patient registries and patient case studies reviewed by our expert panel.

Presentations

Title Time Calendar .ics
Welcome and Introduction
02 June 2021 18:15 - 18:25 .ics
Going Beyond: Long-term Treatment Results with Olumiant in RA
02 June 2021 18:25 - 18:50 .ics
Olumiant RWE: Across Continents and Circumstances
02 June 2021 18:50 - 19:15 .ics
Panel Discussion and Case Studies
02 June 2021 19:15 - 19:43 .ics
Summary and Close
02 June 2021 19:43 - 19:45 .ics